Joseph R Eastman, MD | |
1717 Arlington Ave, Caldwell, ID 83605-4802 | |
(208) 455-3798 | |
Not Available |
Full Name | Joseph R Eastman |
---|---|
Gender | Male |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 1717 Arlington Ave, Caldwell, Idaho |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396772273 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | M9313 (Idaho) | Primary |
207ZB0001X | Pathology - Blood Banking & Transfusion Medicine | M9313 (Idaho) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Joseph R Eastman, MD 19951 Mariner Ave, Suite160, Torrance, CA 90503-1672 Ph: (310) 225-3244 | Joseph R Eastman, MD 1717 Arlington Ave, Caldwell, ID 83605-4802 Ph: (208) 455-3798 |
News Archive
A rare, small RNA turns a gene-splicing machine into a switch that controls the expression of hundreds of human genes. Howard Hughes Medical Institute Investigator and professor of Biochemistry Gideon Dreyfuss, PhD, and his team from the Perelman School of Medicine at the University of Pennsylvania, discovered an entirely new aspect of the gene-splicing process that produces messenger RNA (mRNA).
A novel therapy technique invented by researchers at The University of Texas at Dallas has been shown in a pilot study to double the rate of upper limb recovery in stroke patients, a leap forward in treating the nearly 800,000 Americans who suffer strokes each year.
Physiological processes in soft tissue pain such as chronic tennis elbow can be explored using diagnostic imaging methods. This is demonstrated by researchers from Uppsala University and the results are now being published in the prestigious journal PLOS ONE.
The WHO on Friday announced "it had delivered the first doses of H1N1 [swine flu] vaccine to Cuba, and a dozen countries in Africa would receive millions of doses in coming weeks," Reuters reports.
In a survey of doctors by Mayo Clinic researchers, most respondents pointed to lawyers, health insurers, hospitals, drug companies and patients as having a large stake in cutting costs.
› Verified 1 days ago